Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_provenance.
- NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_assertion description "[Here, we explore the therapeutic potential of dasatinib, a small-molecule inhibitor that targets multiple cytosolic and membrane-bound tyrosine kinases, including members of the Src kinase family, EphA2, and focal adhesion kinase for the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_provenance.
- NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_assertion evidence source_evidence_literature NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_provenance.
- NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_assertion SIO_000772 19861960 NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_provenance.
- NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_assertion wasDerivedFrom befree-20150227 NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_provenance.
- NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_assertion wasGeneratedBy ECO_0000203 NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP218323.RAzaX34Y8mLpENh88k41NHbWqEn_i9Gkoo-RDivIFYqUc130_provenance.